XTalks

JULY 27, 2023

Last week, the US Food and Drug Administration (FDA) stood by its decision, denying a petition asking it to reevaluate the use of eight ortho-phthalates in food-contacting packaging materials. Related: Is Fiber Based Packaging the Next Trend in Sustainable Food Packaging?

Packaging 98

Packaging Packaging FDA Approval Production 98

Roots Analysis

APRIL 21, 2022

Sustainable packaging is defined as packaging that is safe for individuals, as well as the environment, while meeting all requirements for performance, cost and ease of fabrication. The continuously growing pipeline of pharmaceutical drug candidates has inadvertently led to an increase in the demand for product packaging solutions.

Packaging 52

Packaging Packaging Marketing Containment 52

Pharmaceutical Technology

APRIL 3, 2023

The European Commission (EC) has granted marketing authorisation for Sandoz’s biosimilar Hyrimoz (adalimumab) citrate-free high-concentration formulation (HCF). With eight marketed biosimilars, Sandoz is offering the broadest biosimilar portfolio and is the leading biosimilars company in Europe, with more than two decades of experience.

Marketing 264

Marketing Medicine Packaging Packaging 264

Roots Analysis

APRIL 20, 2022

On an average, around 50 drugs are approved by the US Food and Drug Administration (US FDA) annually. In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 trillion in 2023.

Packaging 52

Packaging Packaging Marketing Production 52

XTalks

MAY 13, 2022

A container closure system consists of all the packaging components that contain and protect a pharmaceutical product. They provide specific guidance on packaging requirements for closed closure integrity (CCI) and general integrity testing. Container Closure Systems. Container closure systems are highly regulated by health agencies.

Packaging 98

Packaging Packaging Containment Production 98

World of DTC Marketing

MARCH 9, 2021

SUMMARY : DTC marketers are spending tens of millions of dollars on programmatic ads that are full of fraud and have low click-through rates but they have yet to embrace email marketing which has an average click-through rate of 3.43%. The key to effective email marketing is segmentation and personalization.

Marketing 289

Marketing Branding Packaging Packaging 289

Pharma Mirror

NOVEMBER 4, 2022

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.

Marketing 130

Marketing Packaging Packaging Manufacturing 130

Pharma Packaging Solutions

OCTOBER 6, 2021

Over the years, more and more pharmaceutical companies have moved away from in-house packaging operations and toward pharmaceutical contract packaging. Packaging Innovation. Packaging Innovation. Developing new packaging formats can be expensive, and not every new design will have staying power.

Packaging 52

Packaging Packaging Pharma Companies Contract Packaging 52

Pharmaceutical Technology

NOVEMBER 21, 2022

Japan is currently the fourth largest market in the world. Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 Other contributing factors include the decreasing number of post-market studies and difficulties in primary research and manufacturing.

Marketing 173

Marketing Sales Manufacturing Drugs 173

Outsourcing Pharma

NOVEMBER 10, 2021

According to the market intelligence firm, automation appeals to drug packaging and manufacturing firms, thanks to their productivity-boosting potential.

Packaging 69

Packaging Packaging Pharma Packaging Manufacturing 69

Pharmaceutical Technology

MAY 26, 2023

The European Medicines Agency (EMA) has accepted two marketing authorisation applications (MAA) from Sandoz for the proposed biosimilar denosumab. The submission was supported by a comprehensive analytical and clinical data package, including data from a Phase I PK/PD similarity study and the integrated Phase I/III ROSALIA clinical trial.

Marketing 130

Marketing Packaging Packaging Medicine 130

Fierce Pharma

FEBRUARY 5, 2024

If a new package of pivotal data satisfies the FDA, GSK could have another run at the U.S. | If a new package of pivotal data satisfies the FDA, GSK could have another run at the U.S. multiple myeloma market with its previously withdrawn BMCA-targeted antibody-drug conjugate, Blenrep.

Packaging 108

Packaging Packaging Antibody Marketing 108

XTalks

AUGUST 10, 2020

The US Food and Drug Administration (FDA) announced a voluntary phase-out of certain types of grease-proofing agents on paper and paperboard food packaging. This phase-out comes after an FDA post-market scientific review and analysis from studies found bio-persistence of the grease-proofing substances. What the Report Found.

Packaging 98

Packaging Packaging Contamination Containment 98

XTalks

AUGUST 3, 2023

Last month, the US Food and Drug Administration (FDA) stood by its decision, denying a petition asking it to reevaluate the use of eight ortho-phthalates in food-contacting packaging materials. But recently, the company has struck gold with its character-based marketing.

Packaging 52

Packaging Packaging FDA Approval Sales 52

Pharmaceutical Technology

NOVEMBER 21, 2022

Japan is currently the fourth largest market in the world. Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 Other contributing factors include the decreasing number of post-market studies and difficulties in primary research and manufacturing.

Marketing 130

Marketing Sales Manufacturing Drugs 130

XTalks

DECEMBER 29, 2021

Bayer has announced that all of its products will have 100 percent green packaging by 2030. This means all of the company’s over-the-counter (OTC) drugs and supplements such as pain, allergy and cold medications, and vitamins will have brand packaging that is 100 percent recyclable or reusable in less than ten years’ time.

Packaging 59

Packaging Packaging Production Allergies 59

Pharmaceutical Technology

NOVEMBER 30, 2022

Crossing the approval hurdle for a new drug is a big milestone for pharmaceutical companies. However, efficiently manufacturing the drug represents another barrier to cross before realizing the full revenue potential then successfully. The EMA had provided a positive opinion for this marketing authorization back in July.

Manufacturing 130

Manufacturing Packaging Packaging Drugs 130

Pharmaceutical Technology

SEPTEMBER 8, 2022

Increasing drug failure rates and essential drug shortages have driven the growth of the compounding pharmacies market, which has a high growth potential, especially in emerging economies. Discover the top pharmaceutical compounding companies in contract marketing. Packaging. • Packaging. • Excipients.

Marketing 130

Marketing Pharmacy Containment Sales 130

Pharmaceutical Technology

APRIL 14, 2023

The US Food and Drug Administration (FDA) has rejected Eli Lilly’s biologic licence application (BLA) for the ulcerative colitis (UC) drug mirikizumab over manufacturing concerns. No concerns related to the clinical data package, safety or the medicine label. The regulator has issued a complete response letter.

Manufacturing 130

Manufacturing Drugs Hormones Packaging 130

Pharmaceutical Technology

APRIL 24, 2023

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to XORTX Therapeutics’ oxypurinol to treat autosomal dominant polycystic kidney disease (ADPKD) patients. This designation was a significant and critical milestone for all of the staff and management at the company.

Drugs 130

Drugs Packaging Packaging Marketing 130

Pharmaceutical Technology

DECEMBER 12, 2022

Pharmaceutical companies often outsource different parts of the manufacturing process, including the production of small molecule active pharmaceutical ingredients (APIs) and parenteral packaging, to contract manufacturing organizations (CMOs). Previously, Iomab-B received an EMA orphan drug designation for patients with this condition.

Manufacturing 147

Manufacturing Drugs Packaging Packaging 147

Pharmaceutical Technology

SEPTEMBER 20, 2022

Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Identifying the top commercial dose (non-sterile) companies in contract marketing.

Marketing 130

Marketing Drug Delivery Systems Production Containment 130

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.

Gene Therapy 162

Gene Therapy Packaging Packaging Contract Packaging 162

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

Pharma Marketing Network

AUGUST 9, 2023

The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Marketing 52

Marketing Compliance Packaging Packaging 52

Pharmaceutical Technology

APRIL 5, 2023

The European Medicines Agency (EMA) has announced plans to expedite scientific advice and support the preparation of regulatory packages under its PRIority Medicines (PRIME) scheme. These meetings will be held to help drug developers prepare for their MAAs through an assessment of development plans amongst other things.

Development 130

Development Drugs Medicine Production 130

Antidote

JULY 27, 2023

Before any new therapy can be put on the market, it must be tested to ensure its safety and effectiveness, and the research for this process is done through clinical trials.

Clinical Research 98

Clinical Research Research Clinical Trials Clinical Trials 98

XTalks

FEBRUARY 13, 2024

However, the line between enticing marketing and misleading information can sometimes blur, leading to controversies and legal actions. This dynamic has propelled misleading advertisement lawsuits into the spotlight, with several high-profile cases raising questions about the integrity of food marketing and its impact on consumer trust.

Marketing 59

Marketing Containment Production Packaging 59

FDA Law Blog

JANUARY 3, 2024

Palmer & Riëtte van Laack — Most of us love our furry friends, and with the boom in pet ownership during the pandemic, it is no surprise that the market for pet products has become enormous. CVM does not regulate the practice of veterinary medicine (that’s a state licensing board) or vaccines for animal diseases (that’s USDA).

Drugs 59

Drugs Production Licensing Licensing 59

Pharma Marketing Network

AUGUST 9, 2023

The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Marketing 40

Marketing Compliance Packaging Packaging 40

Pharmaceutical Technology

MAY 1, 2023

Nicox’s Chinese partner Ocumension Therapeutics has secured priority review status for the New Drug Application (NDA) for Zerviate (cetirizine ophthalmic solution), 0.24%, from China’s National Medical Products Administration (NMPA). It has been approved to treat ocular itching that is associated with allergic conjunctivitis in the US.

Licensing 162

Licensing Licensing Sales Packaging 162

pharmaphorum

OCTOBER 12, 2022

Primary Packaging Development. Connected Drug Delivery Devices. Benefits of Attending: Engage with industry representatives on the latest trends within the pre-filled syringe and injectable device market. Hear about new technological advances in the delivery of large volume drugs. find out more at [link].

Drugs 52

Drugs Packaging Packaging Drug Delivery 52

Pharmaceutical Technology

SEPTEMBER 5, 2022

Wholesale distributors are responsible for guaranteeing product quality and preventing the influx of counterfeited drugs. Wholesalers can be either full-line wholesalers, who purchase the complete product line of a company, or specialised companies, which purchase speciality drugs to sell to clinics and hospitals. GDP and GMP advisory.

Packaging 130

Packaging Packaging Compliance Manufacturing 130

Pharmaceutical Technology

JUNE 14, 2023

Navigating the complexities of pharma and biotech packaging services can be difficult. With the growing number of complex therapies that require specialized packaging and handling requirements, selecting the right contract packaging organization (CPO) involves evaluating what services and additional benefits they can bring to your business.

Contract Packaging 130

Contract Packaging Packaging Packaging Development 130

Pharmaceutical Technology

MARCH 10, 2023

Lebanon’s ongoing economic crisis and changes in pricing strategies have caused monumental price hikes that impact market access. Lebanon’s P&R system In Lebanon, drug prices are reviewed and determined by the Ministry of Public Health (MoPH) during the registration process.

Marketing 130

Marketing Branding Manufacturing Medicine 130

Drug Discovery World

JUNE 23, 2023

FDA approves first gene therapy for Duchenne muscular dystrophy Sarepta Therapeutics’ Elevidys has become the first gene therapy for Duchenne muscular dystrophy (DMD) to gain marketing authorisation in the US. The post This week in drug discovery (19-23 June) appeared first on Drug Discovery World (DDW).

Gene Therapy 52

Gene Therapy Drugs Gene FDA Approval 52

pharmaphorum

DECEMBER 10, 2021

Already scrambling to refile its obeticholic acid (OCA) drug for non-alcoholic steatohepatitis (NASH) after the FDA rejected it last year, Intercept Pharma was hoping for more luck in Europe, but has now withdrawn its EU marketing application. Shares in Intercept slipped around 15% after it announced the news.

Drugs 97

Drugs Sales Marketing Packaging 97